Human epidermal growth factor receptor 2 testing in breast cancer AC Wolff, MR Somerfield, M Dowsett, MEH Hammond, DF Hayes, ... Archives of pathology & laboratory medicine 147 (9), 993-1000, 2023 | 5994 | 2023 |
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice … AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ... Journal of clinical oncology 31 (31), 3997-4013, 2013 | 5442 | 2013 |
Comprehensive molecular characterization of gastric adenocarcinoma Cancer Genome Atlas Research Network Nature 513 (7517), 202, 2014 | 5225 | 2014 |
Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4933 | 2013 |
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4539 | 2018 |
Comprehensive genomic characterization of squamous cell lung cancers Cancer Genome Atlas Research Network Nature 489 (7417), 519, 2012 | 3684 | 2012 |
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2715 | 2015 |
Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2650 | 2014 |
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ... Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018 | 2605 | 2018 |
Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556. e25, 2017 | 2272 | 2017 |
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2221 | 2018 |
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011 | 2058 | 2011 |
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1773* | 2020 |
Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017 | 1582 | 2017 |
A short history of the polymerase chain reaction JMS Bartlett, D Stirling PCR protocols, 3-6, 2003 | 964 | 2003 |
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018 | 938 | 2018 |
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of Oncology 25 (8), 1536-1543, 2014 | 825 | 2014 |
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 742 | 2003 |
An international Ki67 reproducibility study MYC Polley, SCY Leung, LM McShane, D Gao, JC Hugh, ... Journal of the National Cancer Institute 105 (24), 1897-1906, 2013 | 671 | 2013 |
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations G Sauter, J Lee, JMS Bartlett, DJ Slamon, MF Press Journal of Clinical Oncology 27 (8), 1323-1333, 2009 | 651 | 2009 |